Proton pump inhibitors and fracture risk. The HUNT study, Norway

Osteoporosis International Nov 24, 2019

Hoff M, Skovlund E, Skurtveit S, et al. - Data from the Nord-Trøndelag Health Study, The Fracture registry in Nord-Trøndelag, and the Norwegian Prescription Database, comprising of 15,017 women and 13,241 men aged 50–85 years were used in order to determine whether proton pump inhibitors (PPIs) and fracture risk were associated with each other. A total of 266 women and 134 men had a first hip fracture and 662 women and 127 men, a first forearm fracture, during a median of 5.2 years follow-up. Using PPIs, the proportion of females and males was 17.9% and 15.5%, respectively. Thus, it was noted that the use of PPIs was not related to a heightened risk of fractures.
Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen